Clinical epidemiology and pharmacoepidemiology studies with real-world databases

S Yoshida, M Takeuchi, S Tanaka-Mizuno… - Proceedings of the …, 2022 - jstage.jst.go.jp
Hospital-based registry data, including patients' information collected by academic societies
or government based research groups, were previously used for clinical research in Japan …

Venous thromboembolism in kidney diseases and genetic predisposition

T Wu, LV Tang, Y Hu - Kidney Diseases, 2022 - karger.com
Background: Many renal diseases have been associated with profound clinical effects on
thrombosis. To our knowledge, patients with nephrotic syndrome (NS) and chronic kidney …

Primary glomerular diseases and long‐term adverse health outcomes: A nationwide cohort study

AL Faucon, S Lando, C Chrysostomou… - Journal of Internal …, 2024 - Wiley Online Library
Background Although glomerular diseases are the third most frequent cause of end‐stage
kidney disease worldwide, little is known about their long‐term outcomes. Methods In …

[HTML][HTML] Comparative effectiveness and safety of edoxaban, rivaroxaban, and apixaban in patients with venous thromboembolism: A cohort study

T Fukasawa, T Seki, M Nakashima… - Journal of Thrombosis and …, 2022 - Elsevier
Background Although several studies have compared the effectiveness and safety of
rivaroxaban and apixaban in patients with venous thromboembolism (VTE), direct …

Risk factors for recurrence of peritonsillar abscess

K Mizuno, M Takeuchi, Y Kishimoto, K Omori… - The …, 2023 - Wiley Online Library
Objectives This study aimed to investigate the risk factors associated with peritonsillar
abscess (PTA) recurrence in adult patients. Methods This retrospective cohort study used a …

Risk of arterial thromboembolism, venous thromboembolism, and bleeding in patients with nephrotic syndrome: a population-based cohort study

SV Vestergaard, H Birn, B Darvalics, D Nitsch… - The American Journal of …, 2022 - Elsevier
Background Although venous thromboembolism is a well-known complication of nephrotic
syndrome, the long-term absolute and relative risks of arterial thromboembolism, venous …

Unchanged incidence of major adverse events amidst rising surgical interventions for osteoporotic vertebral fractures, 2015–2021

S Masuda, T Fukasawa, B Otsuki, K Murata… - Archives of …, 2024 - Springer
This study investigated treatment trends and major adverse events in patients hospitalized
for osteoporotic vertebral fracture (OVF). The frequency of surgical interventions for OVF …

Incidence of surgical site infection following lateral lumbar interbody fusion compared with posterior/transforaminal lumbar interbody fusion: a propensity score …

S Masuda, T Fukasawa, M Takeuchi, S Fujibayashi… - Spine, 2023 - journals.lww.com
Study Design. Retrospective cohort study. Objective. The objective of this study was to
compare the incidence of surgical site infection (SSI) after lateral lumbar interbody fusion …

Serum PLA2R antibody as a predictive biomarker for venous thromboembolism risk in primary membranous nephropathy

J Li, X Wang, S Jiang, W Li - Medicina Clínica (English Edition), 2023 - Elsevier
Background Patients with nephrotic syndrome are at high risk of venous thromboembolism
(VTE), especially for primary membranous nephropathy (PMN). The phospholipase A2 …

Thromboembolism in nephrotic syndrome: controversies and uncertainties

K Parker, O Ragy, P Hamilton, J Thachil… - Research and Practice …, 2023 - Elsevier
Thromboembolism is one of the most serious complications of nephrotic syndrome including
both arterial and venous thromboembolic events. Rates of thromboembolism depend on a …